Type-2-Diabetes: Canagliflozin reduces cardiovascular Risk

被引：0
|
作者：
Lichert, Frank
机构：
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2017年 / 142卷 / 22期
关键词：
D O I：
10.1056/NEJMoa.1611925
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1647 / 1647
页数：1
相关论文
共 50 条
  • [31] The CANVAS Program: implications of canagliflozin on reducing cardiovascular risk in patients with type 2 diabetes mellitus
    Salvatore Carbone
    Dave L. Dixon
    Cardiovascular Diabetology, 18
  • [32] Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus
    Shusuke Yagi
    Yukina Hirata
    Takayuki Ise
    Kenya Kusunose
    Hirotsugu Yamada
    Daiju Fukuda
    Hotimah Masdan Salim
    Gulinu Maimaituxun
    Susumu Nishio
    Yuriko Takagawa
    Saori Hama
    Tomomi Matsuura
    Koji Yamaguchi
    Takeshi Tobiume
    Takeshi Soeki
    Tetsuzo Wakatsuki
    Ken-ichi Aihara
    Masashi Akaike
    Michio Shimabukuro
    Masataka Sata
    Diabetology & Metabolic Syndrome, 9
  • [33] Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes
    Oikonomou, Evangelos K.
    Suchard, Marc A.
    McGuire, Darren K.
    Khera, Rohan
    DIABETES CARE, 2022, 45 (04) : 965 - 974
  • [34] Diabetes Risk "Obesity-Paradox" in Type-2-Diabetes is not confirmed
    Bolte, Laura
    AKTUELLE ERNAHRUNGSMEDIZIN, 2014, 39 (03): : 140 - 140
  • [35] Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus
    Yagi, Shusuke
    Hirata, Yukina
    Ise, Takayuki
    Kusunose, Kenya
    Yamada, Hirotsugu
    Fukuda, Daiju
    Salim, Hotimah Masdan
    Maimaituxun, Gulinu
    Nishio, Susumu
    Takagawa, Yuriko
    Hama, Saori
    Matsuura, Tomomi
    Yamaguchi, Koji
    Tobiume, Takeshi
    Soeki, Takeshi
    Wakatsuki, Tetsuzo
    Aihara, Ken-ichi
    Akaike, Masashi
    Shimabukuro, Michio
    Sata, Masataka
    DIABETOLOGY & METABOLIC SYNDROME, 2017, 9
  • [36] Prevention of the Type-2-Diabetes
    Stefan, N.
    Fritsche, A.
    Haering, H. -U.
    DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 (04) : R57 - R68
  • [37] Diabetes: Lower risk of cardiovascular death with canagliflozin
    Huynh K.
    Nature Reviews Cardiology, 2017, 14 (8) : 442 - 442
  • [38] Therapy of Type-2-Diabetes
    Landgraf, Ruediger
    Aberle, Jens
    Birkenfeld, Andreas L.
    Gallwitz, Baptist
    Kellerer, Monika
    Klein, Harald
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Reuter, Hans-Martin
    Siegel, Erhard
    DIABETOLOGE, 2021, 17 (04): : 422 - 447
  • [39] Therapy of Type-2-Diabetes
    Landgraf, Ruediger
    Kellerer, Monika
    Fach, Eva-Maria
    Gallwitz, Baptist
    Hamann, Andreas
    Joost, Hans-Georg
    Klein, Harald
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Reuter, Hans-Martin
    Schreiber, Stephan
    Siegel, Erhard
    DIABETOLOGIE UND STOFFWECHSEL, 2017, 12 : S141 - S156
  • [40] The significance of the deep sleep for the risk of development of a Type-2-Diabetes
    Jecht, M.
    DIABETOLOGE, 2008, 4 (02): : 124 - 125
12345